← Back to Search

Behavioral Intervention

Ecologial Momentary Assessment settings for Ecological Momentary Assessment (Exemplar Trial)

N/A
Waitlist Available
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion for each participant, 28 days
Awards & highlights

Exemplar Trial Summary

This trial is testing different ways to make it less disruptive and burdensome to do ecological momentary assessments (EMAs), which are measurements of behavior and experience in real-time. They aim to find the best combination of components to achieve the highest compliance rates for smartphone-based EMAs.

Exemplar Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion for each participant, 28 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion for each participant, 28 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of assigned daily smartphone surveys that are completed.
Secondary outcome measures
Number of minutes required to complete the smartphone-based surveys.

Exemplar Trial Design

32Treatment groups
Experimental Treatment
Group I: Group 9Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 15 questions per EMA Fixed schedule Slider first
Group II: Group 8Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 25 questions per EMA Random schedule Likert first
Group III: Group 7Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 25 questions per EMA Random schedule Slider first
Group IV: Group 6Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 25 questions per EMA Fixed schedule Likert first
Group V: Group 5Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 25 questions per EMA Fixed schedule Slider first
Group VI: Group 4Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 15 questions per EMA Random schedule Likert first
Group VII: Group 32Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 25 questions per EMA Random schedule Likert first
Group VIII: Group 31Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 25 questions per EMA Random schedule Slider first
Group IX: Group 30Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 25 questions per EMA Fixed schedule Likert first
Group X: Group 3Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 15 questions per EMA Random schedule Slider first
Group XI: Group 29Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 25 questions per EMA Fixed schedule Slider first
Group XII: Group 28Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 15 questions per EMA Random schedule Likert first
Group XIII: Group 27Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 15 questions per EMA Random schedule Slider first
Group XIV: Group 26Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 15 questions per EMA Fixed schedule Likert first
Group XV: Group 25Experimental Treatment1 Intervention
Payment by % EMAs 4 EMAs per day 15 questions per EMA Fixed schedule Slider first
Group XVI: Group 24Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 25 questions per EMA Random schedule Likert first
Group XVII: Group 23Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 25 questions per EMA Random schedule Slider first
Group XVIII: Group 22Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 25 questions per EMA Fixed schedule Likert first
Group XIX: Group 21Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 25 questions per EMA Fixed schedule Slider first
Group XX: Group 20Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 15 questions per EMA Random schedule Likert first
Group XXI: Group 2Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 15 questions per EMA Fixed schedule Likert first
Group XXII: Group 19Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 15 questions per EMA Random schedule Slider first
Group XXIII: Group 18Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 15 questions per EMA Fixed schedule Likert first
Group XXIV: Group 17Experimental Treatment1 Intervention
Payment by % EMAs 2 EMAs per day 15 questions per EMA Fixed schedule Slider first
Group XXV: Group 16Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 25 questions per EMA Random schedule Likert first
Group XXVI: Group 15Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 25 questions per EMA Random schedule Slider first
Group XXVII: Group 14Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 25 questions per EMA Fixed schedule Likert first
Group XXVIII: Group 13Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 25 questions per EMA Fixed schedule Slider first
Group XXIX: Group 12Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 15 questions per EMA Random schedule Likert first
Group XXX: Group 11Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 15 questions per EMA Random schedule Slider first
Group XXXI: Group 10Experimental Treatment1 Intervention
$1 Payment per EMA 4 EMAs per day 15 questions per EMA Fixed schedule Likert first
Group XXXII: Group 1Experimental Treatment1 Intervention
$1 Payment per EMA 2 EMAs per day 15 questions per EMA Fixed schedule Slider first
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ecologial Momentary Assessment settings
2021
N/A
~420

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,194 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Oklahoma
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Annual Review of Clinical PsychologyJournal
Ecological Momentary Assessment
Shiffman, Saul, Arthur A. Stone, and Michael R. Hufford. 2008. “Ecological Momentary Assessment”. Annual Review of Clinical Psychology. Annual Reviews. doi:10.1146/annurev.clinpsy.3.022806.091415.
Psychological AssessmentJournal
Response Compliance and Predictors Thereof in Studies Using the Experience Sampling Method.
Rintala, Aki, Martien Wampers, Inez Myin-Germeys, and Wolfgang Viechtbauer. 2019. “Response Compliance and Predictors Thereof in Studies Using the Experience Sampling Method.”. Psychological Assessment. American Psychological Association (APA). doi:10.1037/pas0000662.
Statistics in MedicineJournal
Factorial Designs for Crossover Clinical Trials
Fletcher, D. J., S. M. Lewis, and J. N. S. Matthews. 1990. “Factorial Designs for Crossover Clinical Trials”. Statistics in Medicine. Wiley. doi:10.1002/sim.4780091002.
AddictionJournal
Compliance with Ecological Momentary Assessment Protocols in Substance Users: A Meta‐analysis
Jones, Andrew, Danielle Remmerswaal, Ilse Verveer, Eric Robinson, Ingmar H. A. Franken, Cheng K. Fred Wen, and Matt Field. 2018. “Compliance with Ecological Momentary Assessment Protocols in Substance Users: A Meta‐analysis”. Addiction. Wiley. doi:10.1111/add.14503.
~125 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top